Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Ubiquigent aggregated by PharmaCompass.com.

    Client Virtual Booth

    UBIQUIGENT

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Ubiquigent
    unitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Sir James Black Centre Dow Street Dundee DD1 5EH Scotland
    Telephone
    Telephone
    +44 (0) 1382 381147
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ubiquigent.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ubiquigent
    Twitter
    Twitter
    https://twitter.com/ubiquigent

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Ubiquigent and Debiopharm team up to advance USP1 inhibitor
    Ubiquigent and Debiopharm team up to advance USP1 inhibitor

    https://www.pharmaceutical-technology.com/news/ubiquigent-and-debiopharm-team-up-to-advance-usp1-inhibitor/

    Jenna Philpott PHARMACEUTICAL TECHNOLOGY
    27 Mar 2024
    Share Share
    Ubiquigent and Debiopharm Enter Agreement to Support for Debio 0432
    Ubiquigent and Debiopharm Enter Agreement to Support for Debio 0432

    https://www.businesswire.com/news/home/20240326540510/en

    BUSINESSWIRE
    26 Mar 2024
    Share Share
    Ubiquigent Enters Agreement With Astellas Subsidiary, Nanna Therapeutics
    Ubiquigent Enters Agreement With Astellas Subsidiary, Nanna Therapeutics

    https://www.businesswire.com/news/home/20240311216568/en

    BUSINESSWIRE
    11 Mar 2024
    Share Share
    Ubiquigent DUB inhibitor pact survives Bristol-Celgene merger
    Ubiquigent DUB inhibitor pact survives Bristol-Celgene merger

    https://www.fiercebiotech.com/biotech/ubiquigent-dub-inhibitor-pact-survives-bristol-celgene-merger

     Nick Paul Taylor FIERCE BIOTECH
    19 Jun 2020
    Share Share
    Ubiquigent Continues Drug Discovery Collaboration With Bristol Myers Squibb
    Ubiquigent Continues Drug Discovery Collaboration With Bristol Myers Squibb

    https://www.businesswire.com/news/home/20200617005035/en

    BUSINESSWIRE
    17 Jun 2020
    Share Share
    Avidity tops up IPO at $298M; Bristol Myers keeps a Celgene discovery pact alive
    Avidity tops up IPO at $298M; Bristol Myers keeps a Celgene discovery pact alive

    https://endpts.com/avidity-tops-up-ipo-at-298m-bristol-myers-keeps-a-celgene-discovery-pact-alive/

    ENDPTS
    17 Jun 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search